Mostrar el registro sencillo del ítem
| dc.contributor.author | Galceran, Jaume | |
| dc.contributor.author | Ameijide, Alberto | |
| dc.contributor.author | Jeghalef, Noura | |
| dc.contributor.author | Sánchez, Antonia | |
| dc.contributor.author | Guevara, Marcela | |
| dc.contributor.author | Bigorra, Jamnica | |
| dc.contributor.author | Gutiérrez, Pilar | |
| dc.contributor.author | Boone, An-L-D | |
| dc.contributor.author | Garrido, Montserrat | |
| dc.contributor.author | Álvarez, Xitama | |
| dc.contributor.author | Vizcaino, Ana | |
| dc.contributor.author | Martín, Isabel | |
| dc.contributor.author | Onaindia, Amaia | |
| dc.contributor.author | Sanclemente, Silvia | |
| dc.contributor.author | Trallero, Jan | |
| dc.contributor.author | Sánchez, María-José | |
| dc.contributor.author | Palacios, María-Isabel | |
| dc.contributor.author | Cleries, Ramon | |
| dc.contributor.author | Carulla, María | |
| dc.date.accessioned | 2026-09-17T12:15:39Z | |
| dc.date.available | 2026-09-17T12:15:39Z | |
| dc.date.issued | 2026-06-18 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/28139 | |
| dc.description.abstract | BACKGROUND: Childhood cancer survivors have a higher risk of developing malignancies later in life compared with individuals of similar age in the general population. In Spain, population-based evidence on second malignant neoplasms (SMNs) is limited. This study aimed to estimate survival following childhood cancer diagnosis and to assess the risk of SMNs in Spain. METHODS: This population-based registry study used data from 12 cancer registries within the Spanish Network of Cancer Registries (REDECAN). All malignancies of sites and non-malignant central nervous system (CNS) tumors diagnosed before age 15 were included. Age-standardized incidence rates (ASIRw) for 2015-2019 were calculated. Five- and 10-year age-adjusted observed survival rates for 1990-1999 and 2000-2009 were estimated. SMN risk was assessed using standardized incidence ratios (SIRs) and excess absolute risks (EARs). RESULTS: The ASIRw for 2015-2019 was 181.3 per million child-years. Ten-year survival increased from 71.3% in 1990-1999 to 75.5% in 2000-2009. The overall risk of developing an SMN was significantly elevated (SIR = 5.67) at 20 years. CONCLUSIONS: Although survival for childhood cancer in Spain was around 75% in 2000-2009, childhood cancer survivors remain at substantially increased risk of SMNs for at least two decades. Efforts to reduce treatment-related toxicity while maintaining survival gains are essential. | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.rights | Atribución/Reconocimiento 4.0 Internaciona | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | * |
| dc.title | Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 42352523 | |
| dc.relation.publisherversion | https://www.mdpi.com/2072-6694/18/12/1991 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.3390/cancers18121991 | |
| dc.journal.title | CANCERS | |
| dc.identifier.essn | 2072-6694 |